Bml Capital Management, LLC Surrozen, Inc. Transaction History

Bml Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$0.44 - $0.89 $602,717 - $1.22 Million	-1,369,813 Reduced 93.88%	89,271 $43.7 Million
Q2 2023 Jul 24, 2023	SELL	$0.55 - $0.72 $19,224 - $25,166	-34,953 Reduced 2.34%	1,459,084 $802 Million
Q1 2023 Apr 14, 2023	BUY	$0.56 - $1.32 $836,660 - $1.97 Million	1,494,037 New	1,494,037 $899 Million

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $371M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bml Capital Management, LLC with notifications on news.